Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diffuse Large B Cell Lymphoma
- Transformed Lymphoma
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04319237
- Collaborators
- Kite, A Gilead Company
- Investigators
- Principal Investigator: Heather Jim, PhD Moffitt Cancer Center Principal Investigator: Fred Locke, MD Moffitt Cancer Center